Social Return on Investment (SROI) Methodology to Account for Value for Money of Health Interventions: The Case of the Psoriasis in Spain
Social Return on Investment (SROI) Methodology to Account for Value for Money of Health Interventions: The Case of the Psoriasis in Spain
Friday, June 24, 2016: 9:00 AM-10:30 AM
105 Dwinelle (Dwinelle Hall)
Objective: The social return on investment (SROI) evaluates health technologies including patients and their social environment. Its application in psoriasis has enabled predict how social value is created from an ideal approach.
Material and Methods: We used the SROI methodology prospective, with a time horizon of one year, measuring the change being the introduction of measures in the current approach of psoriasis. This has allowed maximize social value generated by such activities. Calculating a cost-benefit ratio is useful in monetary terms the social and economic changes generated. For that we have taken into account the different levels of the disease, ie, diagnosis, monitoring and treatment for mild, moderate and severe psoriasis. The information needed for this method has been validated by a multidisciplinary panel of experts and surveys via online patients.
Results: The survey results have shown the reality of patients with psoriasis. They have a high involvement in all areas of their lives, both family, work and social emotional level. As estimated so far assume that the investment does each euro the ideal approach to psoriasis report a positive return on investment.
Conclusions: The current social burden of psoriasis can be reduced with appropriate interventions. The SROI shows that prioritized investment in the most appropriate criteria, maximizing the social and economic impact.
Material and Methods: We used the SROI methodology prospective, with a time horizon of one year, measuring the change being the introduction of measures in the current approach of psoriasis. This has allowed maximize social value generated by such activities. Calculating a cost-benefit ratio is useful in monetary terms the social and economic changes generated. For that we have taken into account the different levels of the disease, ie, diagnosis, monitoring and treatment for mild, moderate and severe psoriasis. The information needed for this method has been validated by a multidisciplinary panel of experts and surveys via online patients.
Results: The survey results have shown the reality of patients with psoriasis. They have a high involvement in all areas of their lives, both family, work and social emotional level. As estimated so far assume that the investment does each euro the ideal approach to psoriasis report a positive return on investment.
Conclusions: The current social burden of psoriasis can be reduced with appropriate interventions. The SROI shows that prioritized investment in the most appropriate criteria, maximizing the social and economic impact.